Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation

This study broadens the potential application of LHQW and provides insights for liver cancer treatment.PMID:38493972 | DOI:10.1016/j.gene.2024.148383

Source: Gene - March 17, 2024 Category: Genetics & Stem Cells Authors: Jinrui Wei Xuqi Zhao Fuli Long Kunpeng Tian Lichuan Wu Source Type: research